These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19799612)

  • 21. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
    Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
    J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.
    Francisco JA; Cerveny CG; Meyer DL; Mixan BJ; Klussman K; Chace DF; Rejniak SX; Gordon KA; DeBlanc R; Toki BE; Law CL; Doronina SO; Siegall CB; Senter PD; Wahl AF
    Blood; 2003 Aug; 102(4):1458-65. PubMed ID: 12714494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
    Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
    Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
    Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
    Ishikawa C; Arbiser JL; Mori N
    Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL).
    Tanaka Y; Tanaka R; Imaizumi N; Mizuguchi M; Takahashi Y; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Masuzaki H; Fukushima T
    Front Immunol; 2022; 13():921606. PubMed ID: 36177005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma.
    Aikawa A; Kozako T; Kato N; Ohsugi T; Honda SI
    Eur J Pharmacol; 2023 Dec; 961():176180. PubMed ID: 37956732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.
    Bhatt S; Ashlock BM; Natkunam Y; Sujoy V; Chapman JR; Ramos JC; Mesri EA; Lossos IS
    Blood; 2013 Aug; 122(7):1233-42. PubMed ID: 23838350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
    Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
    Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
    Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia.
    Hata T; Fujimoto T; Tsushima H; Murata K; Tsukasaki K; Atogami S; Sohda H; Honda S; Mine M; Yamada Y; Ikeda S; Kamihira S; Tomonaga M
    Leukemia; 1999 Feb; 13(2):215-21. PubMed ID: 10025895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies.
    Pinter-Brown LC
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1883-7. PubMed ID: 19012503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (IV): phenanthroindolizidine alkaloids from Tylophora tanakae leaves.
    Nakano D; Ishitsuka K; Ikeda M; Tsuchihashi R; Okawa M; Okabe H; Tamura K; Kinjo J
    J Nat Med; 2015 Jul; 69(3):397-401. PubMed ID: 25840916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How I treat adult T-cell leukemia/lymphoma.
    Bazarbachi A; Suarez F; Fields P; Hermine O
    Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cell lines.
    Ishikawa C; Jomori T; Tanaka J; Senba M; Mori N
    Int J Oncol; 2016 Oct; 49(4):1713-21. PubMed ID: 27499015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
    Moles R; Bai XT; Chaib-Mezrag H; Nicot C
    J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.
    Zhang Z; Zhang M; Ravetch JV; Goldman C; Waldmann TA
    Blood; 2003 Jul; 102(1):284-8. PubMed ID: 12649132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.
    Zhang M; Yao Z; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Janik J; Brechbiel MW; Waldmann TA
    Blood; 2006 Jul; 108(2):705-10. PubMed ID: 16551968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.